How A Cannabis Company Is Taking A Page Out Of The Pharmaceutical Playbook

In the weed world, Big Pharma is typically seen as an enemy. It’s the industry that pushed opioids over a potentially safer solution to chronic pain. It’s the industry that has scored Schedule II and III status for synthetic THC, while naturally occurring THC in cannabis plants remain in Schedule I. It’s the …

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *